Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
European Urology
Published October 22, 2026
Circulating Immune and Cancer Driver Gene Biomarkers Precede Prostate Cancer Diagnosis by over 10...
October 23, 2026
Medspoke
Medspoke
Clinical Cancer Research
Published October 21, 2026
00:00
--:--
DuoBody®-FAPαxDR4 is a novel DR4 agonist that induces potent antitumor activity through FAPα-depe...
October 23, 2026
Share
DuoBody®-FAPαxDR4 is a novel DR4 agonist that induces potent antitumor activity through FAPα-dependent, DR4-transactivation-mediated apoptosis.
https://www.medspoke.co/channel_journal?id=686&tap_id=16127
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Clinical Cancer Research
Published October 21, 2026
Serial circulating tumour DNA monitoring in first-line advanced NSCLC (COPE): a randomized, two-a...
October 23, 2026
Why are you reporting this TALK?
